Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.519
+0.029 (5.90%)
At close: Nov 4, 2024, 4:00 PM
0.510
-0.010 (-1.83%)
After-hours: Nov 4, 2024, 5:50 PM EST
Sensei Biotherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 11.89 | 13.01 | 17.8 | 7.16 | 16.6 | 0.25 | Upgrade
|
| Short-Term Investments | 40.4 | 52.75 | 89.32 | 140.46 | - | - | Upgrade
|
| Cash & Short-Term Investments | 52.29 | 65.76 | 107.12 | 147.62 | 16.6 | 0.25 | Upgrade
|
| Cash Growth | -33.68% | -38.61% | -27.44% | 789.50% | 6511.95% | -61.56% | Upgrade
|
| Prepaid Expenses | 1.51 | 1.17 | 1.13 | 0.55 | 1.38 | 0.25 | Upgrade
|
| Other Current Assets | 0.14 | 0.33 | 0.34 | 0.37 | 2.11 | - | Upgrade
|
| Total Current Assets | 53.94 | 67.25 | 108.59 | 148.54 | 20.08 | 0.5 | Upgrade
|
| Property, Plant & Equipment | 5.77 | 7.04 | 9.72 | 4.64 | 1.27 | 0.27 | Upgrade
|
| Other Long-Term Assets | 0.09 | 0.09 | 0.06 | 0.04 | 0.09 | 0.45 | Upgrade
|
| Total Assets | 59.8 | 74.37 | 118.38 | 153.23 | 21.43 | 1.22 | Upgrade
|
| Accounts Payable | 1.65 | 1.69 | 4.47 | 2.46 | 3.88 | 3.55 | Upgrade
|
| Accrued Expenses | 0.85 | 1.51 | 2.46 | 1.75 | 0.92 | 2.08 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 16.06 | Upgrade
|
| Current Portion of Leases | 2.46 | 2.44 | 2.13 | 0.68 | 0.03 | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.03 | Upgrade
|
| Total Current Liabilities | 4.95 | 5.64 | 9.07 | 4.89 | 4.83 | 21.71 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.57 | - | Upgrade
|
| Long-Term Leases | 2.59 | 3.77 | 5.9 | 1.67 | 0.09 | - | Upgrade
|
| Other Long-Term Liabilities | 0.07 | 0.07 | - | 0.15 | 0.05 | 0.62 | Upgrade
|
| Total Liabilities | 7.61 | 9.48 | 14.97 | 6.71 | 5.54 | 22.33 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | - | - | Upgrade
|
| Additional Paid-In Capital | 299.31 | 297 | 302.2 | 296.05 | 55.97 | 23.65 | Upgrade
|
| Retained Earnings | -247.03 | -231.9 | -197.79 | -149.21 | -112.41 | -92.31 | Upgrade
|
| Comprehensive Income & Other | -0.09 | -0.21 | -1 | -0.33 | - | - | Upgrade
|
| Total Common Equity | 52.19 | 64.9 | 103.41 | 146.51 | -56.44 | -68.66 | Upgrade
|
| Shareholders' Equity | 52.19 | 64.9 | 103.41 | 146.51 | 15.89 | -21.12 | Upgrade
|
| Total Liabilities & Equity | 59.8 | 74.37 | 118.38 | 153.23 | 21.43 | 1.22 | Upgrade
|
| Total Debt | 5.05 | 6.21 | 8.03 | 2.35 | 0.69 | 16.06 | Upgrade
|
| Net Cash (Debt) | 47.24 | 59.55 | 99.08 | 145.27 | 15.91 | -15.8 | Upgrade
|
| Net Cash Growth | -34.00% | -39.90% | -31.79% | 813.00% | - | - | Upgrade
|
| Net Cash Per Share | 1.88 | 2.13 | 3.23 | 5.24 | 9.87 | -43.02 | Upgrade
|
| Filing Date Shares Outstanding | 25.15 | 25.07 | 30.97 | 30.68 | 30.59 | 0.37 | Upgrade
|
| Total Common Shares Outstanding | 25.12 | 25.03 | 30.76 | 30.61 | 1.88 | 0.37 | Upgrade
|
| Working Capital | 49 | 61.61 | 99.52 | 143.65 | 15.25 | -21.21 | Upgrade
|
| Book Value Per Share | 2.08 | 2.59 | 3.36 | 4.79 | -30.10 | -185.80 | Upgrade
|
| Tangible Book Value | 52.19 | 64.9 | 103.41 | 146.51 | -56.44 | -68.66 | Upgrade
|
| Tangible Book Value Per Share | 2.08 | 2.59 | 3.36 | 4.79 | -30.10 | -185.80 | Upgrade
|
| Machinery | 2.68 | 2.64 | 3.24 | 5.58 | 1.86 | 0.66 | Upgrade
|
| Leasehold Improvements | 0.25 | 0.25 | 0.25 | 0.25 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.